Phenytoin is used for: Epilepsy; Tonic-clonic status epilepticus.
Recorded in the NepalDoc medicine catalog for Phenytoin.
Parenteral Phenytoin Sodium Injection is indicated for the treatment of generalized tonic-clonic status epilepticus, and prevention and treatment of seizures occurring during neurosurgery. Intravenous phenytoin can also be substituted, as short-term use, for oral phenytoin.
From the U.S. FDA-approved label for Phenytoin. Full label: DailyMed.
Parenteral Phenytoin Sodium Injection is indicated for the treatment of generalized tonic-clonic status epilepticus, and prevention and treatment of seizures occurring during neurosurgery. Intravenous phenytoin can also be substituted, as short-term use, for oral phenytoin. Parenteral phenytoin should be used only when oral phenytoin administration is not possible.
From the U.S. FDA-approved label for Phenytoin. Full label: DailyMed.
For Status Epilepticus and Non-emergent Loading Dose: Adult loading dose is 10 to 15 mg/kg at a rate not exceeding 50 mg/min. Pediatric loading dose is 15 to 20 mg/kg at a rate not exceeding 1 to 3 mg/kg/min or 50 mg/min, whichever is slower. Continuous monitoring of the electrocardiogram, blood pressure, and respiratory function is essential.
Directions from the U.S. FDA-approved label for Phenytoin — your doctor or pharmacist may advise differently.
Phenytoin Sodium Injection is contraindicated in patients with: A history of hypersensitivity to phenytoin, its inactive ingredients, or other hydantoins. Sinus bradycardia, sino-atrial block, second and third degree A-V block, and Adams-Stokes syndrome because of the effect of parenteral phenytoin on ventricular automaticity. A history of prior acute hepatotoxicity attributable to phenytoin.
Excerpt from the U.S. FDA-approved label for Phenytoin. Talk to a pharmacist or doctor before use.
Withdrawal Precipitated Seizure: May precipitate status epilepticus. Dose reductions or discontinuation should be done gradually. Serious Dermatologic Reactions: Discontinue phenytoin at the first sign of a rash, unless the rash is clearly not drug-related. If signs or symptoms suggest SJS/TEN, use of this drug should not be resumed and alternative therapy should be considered. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan hypersensitivity: If signs or symptoms of hypersensitivity are present, evaluate the patient immediately. Discontinue if an alternative etiology cannot be established.
Warnings and precautions excerpt from the U.S. FDA-approved label for Phenytoin — not a complete list. Talk to a pharmacist or doctor before use.
The following serious adverse reactions are described elsewhere in the labeling: Cardiovascular Risk Associated with Rapid Infusion Withdrawal Precipitated Seizure, Status Epilepticus Serious Dermatologic Reactions Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity Hypersensitivity Hepatic Injury Hematopoietic Complications Local toxicity (Including Purple Glove Syndrome) Exacerbation of…
Excerpt from the U.S. FDA-approved label for Phenytoin — not a complete list. Talk to a pharmacist or doctor about side effects.
14 brands · 8 makers in the NepalDoc catalog — see the full Phenytoin guide →
Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F).
Storage information from the U.S. FDA-approved label for Phenytoin.
What is Epileptin 100?
Epileptin 100mg Tablet is a Phenytoin medicine made by Asian Pharmaceuticals Pvt. Ltd. It comes as 100mg Tablet.
What is Epileptin 100 used for?
Phenytoin is used for Epilepsy, Tonic-clonic status epilepticus.
What is the generic name of Epileptin 100?
The generic name of Epileptin 100 is Phenytoin.
Which brands of Phenytoin are available in Nepal?
14 brands of Phenytoin are listed in the NepalDoc catalog, from 8 makers — including Dilantin 50mg Injection, Dilantin 25mg/ ml Suspension, Epileptin 300mg Tablet, Epsolin 100mg Tablet, Eptoin 100mg Tablet, Eptoin 50mg Tablet.
What are the side effects of Phenytoin?
The following serious adverse reactions are described elsewhere in the labeling: Cardiovascular Risk Associated with Rapid Infusion Withdrawal Precipitated Seizure, Status Epilepticus Serious Dermatologic Reactions Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity Hypersensitivity Hepatic Injury Hematopoietic Complications Local toxicity (Including Purple Glove Syndrome) Exacerbation of…
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
